OFFICIAL PUBLICATION OF

by its subsidiary APPco

Ovarian cancer patient wins $525 million from J&J

Sheshtyn Paola 22/08/2017

talc powder talcum ovarian cancer personal care products feminine hygiene

It is the largest payout so far in a string of lawsuits against Johnson & Johnson and its talc-based products A US jury has ordered Johnson & Johnson (J&J) to pay US$417 million (AU$525 million) to California resident Eva Echeverria, 62, who alleged the company failed to adequately warn consumers about the cancer risks of

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

Funding secured for non-8CPA programs

Medschecks and Diabetes MedsCheck are included and funded under the 8CPA. The programs under the 8CPA will be undergoing a…

Anthony Tassone

Eli Lilly clarifies Mounjaro availability

One would think they could have made a commercial decision eith a needle maker to supply requisite number of needles…

Erin Threlfall

Funding secured for non-8CPA programs

This is a big step forward in securing the sustainability and viability of HMRs and RMMRs. Remember there is an…

Debbie Rigby

Funding secured for non-8CPA programs

So well done to the PSA for securing this funding. So important that these very valuable program finally gets looked…

Bente Hart

Ovarian cancer patient wins $525 million from J&J

Previous Reflections on rural Australia

Next Too much medicine?

Shingles: managing a distressing skin condition

Impetigo: cause and treatment

Topical retinoids: versatile skin care ingredients

Ceramides: what are they and why are they important?

MENU

Previous Reflections on rural Australia

Next Too much medicine?

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.